Bioject Medical Technologies Inc. 

(Public, OTC:BJCT)   Watch this stock   
Find more results for BJCT
Nov 10, 2009
Q3 2009 Earnings Release
  

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -11.34% -47.03%
Operating margin -13.68% -47.81%
EBITD margin - -34.82%
Return on average assets -13.27% -44.22%
Return on average equity - -
Employees 33 -

Address

20245 SW 95th Avenue
Tualatin, OR 97062
United States - Map
+1-503-6928001 (Phone)
+1-503-6926698 (Fax)

Website links

Bioject Medical Technologies Inc. discussions

  View all discussions »

Description

Bioject Medical Technologies Inc. is a developer and manufacturer of needle-free injection therapy systems (NFITS). The Company is focused to become a supplier of needle-free injection systems to the pharmaceutical and biotechnology industries. During the year ended December 31, 2008, Bioject Medical Technologies focused its business development efforts on new and existing licensing and supply agreements with pharmaceutical and biotechnology companies. Its pipeline of prospective partnerships remains active. The Company’s NFITS works by forcing liquid medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure medication that penetrates the skin, depositing the medication in the tissue beneath. Bioject Medical Technologies bundles customized needle-free delivery systems with partners’ injectable medications and vaccines.

Officers and directors

David S. Tierney M.D.
Chairman of the Board
Age: 46
Ralph Makar
President, Chief Executive Officer, Director
Age: 48
Richard R. Stout M.D.
Executive Vice President, Chief Medical Officer, Member of Executive Committee
Age: 56
Christine M. Farrell
Vice President - Finance, Member of Executive Committee
Age: 49
John Ruedy M.D.
Director
Age: 77
Edward L. Flynn
Director
Age: 74
Randal D. Chase Ph.D.
Director
Age: 60
Jerald S. Cobbs
Director
Age: 57
Brigid A. Makes
Director
Age: 53